Earnings Feed
Start Free
Home/Filings/4/0001140361-13-028008
4//SEC Filing

ORAMED PHARMACEUTICALS INC. 4

Accession 0001140361-13-028008

$ORMPCIK 0001176309operating
View on SEC.govCompany Profile

Filed

Jul 11, 8:00 PM ET

Accepted

Jul 12, 3:03 PM ET

Size

12.6 KB

Accession

0001140361-13-028008

Insider Transaction Report

Form 4
Period: 2013-06-18
ORAMED PHARMACEUTICALS INC.ORMP
REGALS CAPITAL MANAGEMENT LP
10% Owner
Transactions
  • Small Acquisition

    Common Stock

    2013-06-18$6.40/sh+447$2,861→ 1,318,360 total(indirect: See)
  • Small Acquisition

    Common Stock

    2013-06-19$6.45/sh+103$664→ 1,318,463 total(indirect: See)
  • Purchase

    Common Stock

    2013-07-10$7.40/sh+6,630$49,034→ 1,325,093 total(indirect: See)
Regals Fund LP
10% Owner
Transactions
  • Small Acquisition

    Common Stock

    2013-06-18$6.40/sh+447$2,861→ 1,318,360 total(indirect: See)
  • Purchase

    Common Stock

    2013-07-10$7.40/sh+6,630$49,034→ 1,325,093 total(indirect: See)
  • Small Acquisition

    Common Stock

    2013-06-19$6.45/sh+103$664→ 1,318,463 total(indirect: See)
Slager David Mark
10% Owner
Transactions
  • Small Acquisition

    Common Stock

    2013-06-19$6.45/sh+103$664→ 1,318,463 total(indirect: See)
  • Small Acquisition

    Common Stock

    2013-06-18$6.40/sh+447$2,861→ 1,318,360 total(indirect: See)
  • Purchase

    Common Stock

    2013-07-10$7.40/sh+6,630$49,034→ 1,325,093 total(indirect: See)
Footnotes (2)
  • [F1]Regals Capital Management LP, a Delaware limited partnership ("Regals Management"), the Fund, and David M. Slager ("Mr. Slager"), are the reporting persons (the "Reporting Persons") for the referenced securities. Mr. Slager is Managing Member of the general partner of Regals Management. Regals Management is the investment manager of the Fund. The shares of the issuer's common stock reported herein are held for the account of the Fund.
  • [F2]As a result, each of the Reporting Persons may be deemed to be a beneficial owner of the securities owned by the Fund for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended (the "Act"). Pursuant to Rule 16a-1(a)(4) under the Act, Regals Management and Mr. Slager disclaim beneficial ownership in the securities owned by the Fund except to the extent, if any, of their pecuniary interest therein.

Documents

1 file

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001176309

Filing Metadata

Form type
4
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 3:03 PM ET
Size
12.6 KB
View on SEC.gov